Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

SAFE-PCI for Women (SAFE-PCI)

This study has been terminated.
(Study stopped for Statistical Futility. Low rate of bleeding events made it unlikely there would be statistical power to show a difference in the 2 arms.)
Sponsor:
Collaborators:
American College of Cardiology
Abbott Vascular
Lilly USA
Medtronic
Terumo Medical Corporation
The Medicines Company
Acist Medical Systems
Guerbet
Food and Drug Administration (FDA)
Information provided by (Responsible Party):
Duke University
ClinicalTrials.gov Identifier:
NCT01406236
First received: June 20, 2011
Last updated: January 16, 2015
Last verified: January 2015